CNA Financial’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,270
Closed -$714K 83
2022
Q3
$714K Sell
18,270
-1,280
-7% -$58.6K 0.27% 67
2022
Q2
$799K Buy
19,550
+610
+3% +$28.9K 0.28% 71
2022
Q1
$1.24M Buy
18,940
+860
+5% +$55.7K 0.39% 55
2021
Q4
$1.26M Buy
18,080
+2,480
+16% +$180K 0.33% 72
2021
Q3
$1.08M Buy
15,600
+390
+3% +$30K 0.3% 89
2021
Q2
$1.21M Buy
15,210
+1,210
+9% +$88K 0.34% 74
2021
Q1
$917K Buy
+14,000
New +$862K 0.28% 105

Other funds holding ATRC

CNA Financial's ATRC Position: Q4 2022 in Review

CNA Financial sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 18,270 shares — an estimated $714K sold.

CNA Financial first reported a position in ATRC in Q1 2021 and held it in 7 quarters. The position peaked at $1.26M in Q4 2021. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • CNA Financial reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 18,270 AtriCure shares in Q4 2022, an estimated $714K.
  • CNA Financial first reported a position in AtriCure in Q1 2021 and held it in 7 quarters.
  • CNA Financial's AtriCure position peaked at $1.26M in Q4 2021.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.